Trusted Peptide Supplier for Global Labs and Manufacturers
ACE-031 (CAS 1621169-52-5) High purity peptide Factory manufactured
1 × $42.00
Argatroban Injection 10?mg/20?ml × 2 Vials – For Laboratory Research Use Only
25 × $1.00
ACTH 1-39 | High-Purity Freeze-Dried Peptide Powder for Research
1 × $82.00Subtotal: $149.00
Trusted Peptide Supplier for Global Labs and Manufacturers
What Is Semaglutide? Semaglutide is a GLP-1 receptor agonist initially developed to manage type 2 diabetes. However, in recent years, it has made headlines for its powerful effects on weight…
Read moreIntroduction to Semaglutide: What Is It? Semaglutide has revolutionized the treatment of type 2 diabetes and obesity as a GLP-1 receptor agonist. Originally developed by Novo Nordisk, it is available under brand names like Ozempic…
Read moreIntroduction: The Future of Obesity Treatment The pharmaceutical world is abuzz with excitement over Retatrutide, Eli Lilly’s innovative triple-receptor agonist currently in late-stage clinical trials. As the potential successor to blockbuster…
Read moreIntroduction: A New Hope for Weight Loss In the ever-evolving world of obesity treatment, Retatrutide has emerged as one of the most promising new medications. As the latest development from pharmaceutical giant…
Read moreIntroduction The pharmaceutical world is buzzing with excitement over Retatrutide, Eli Lilly’s innovative triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors. As the successor to blockbuster drugs like Mounjaro (Tirzepatide) and Wegovy (Semaglutide), Retatrutide promises even greater weight…
Read more? Retatrutide Overview Retatrutide (Eli Lilly’s triple-hormone agonist) is the next-generation obesity and type 2 diabetes treatment, outperforming Wegovy® and Mounjaro® in clinical trials with 24.2% average weight loss at 48 weeks. As…
Read more
